Low-Dose aspirin in the primary prevention cof cardiovascular disease shared decision making in clinical practice

JAMA - Journal of the American Medical Association

Volumn 316, Issue 7, 2016, Pages 709-710

  Mora, Samia ^a   Ames, Jeffrey M ^a   Manson, Joann E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Software and Mobile Application Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; BRAIN HEMORRHAGE; CANCER RISK; CASE REPORT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COLORECTAL CANCER; CONSENSUS DEVELOPMENT; CORONARY ARTERY ATHEROSCLEROSIS; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; HYPERTENSION; LIFE EXPECTANCY; LONG TERM CARE; LOW DRUG DOSE; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; MOBILE APPLICATION; NUMBERS NEEDED TO TREAT; PATIENT ATTITUDE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SHARED DECISION MAKING; SHORT SURVEY; SYSTEMATIC REVIEW (TOPIC); AGE; ALGORITHM; BLEEDING; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; COMPLICATION; DECISION MAKING; PEPTIC ULCER; PROCEDURES;

AGE FACTORS; AGED; ALGORITHMS; ASPIRIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COLORECTAL NEOPLASMS; DECISION MAKING; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NUMBERS NEEDED TO TREAT; PEPTIC ULCER; PLATELET AGGREGATION INHIBITORS; PRECISION MEDICINE; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 84987679951     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.8362     Document Type: Short Survey

References (10)

1. Mora S, Manson JE. Aspirin for primary prevention of atherosclerotic cardiovascular disease: advances in diagnosis and treatment. JAMA Intern Med. doi:10.1001/jamainternmed.2016 .2648.
2. Mainous AG, Tanner RJ, Shorr RI, Limacher MC. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012. J AmHeart Assoc. 2014;3(4): e000989.
3. Bibbins-Domingo K; US Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement [published online April 12, 2016]. Ann Intern Med. doi:10.7326/M16-0577.
4. Guirguis-Blake JM, Evans CV, Senger CA, O'Connor EA, Whitlock EP, Whitlock EP. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force [published online April 12, 2016]. Ann Intern Med. doi:10.7326/M15-2113.
5. Whitlock EP,Williams SB, Burda BU, Feightner A, Beil T. Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2015. Evidence Synthesis 132/AHRQ publication 13-05193-ef-1.
6. Whitlock EP, Burda BU,Williams SB, Guirguis-Blake JM, Evans CV. Bleeding risks with aspirin use for primary prevention in adults: a systematic evidence review for the U.S. Preventive Services Task Force [published online April 12, 2016]. Ann Intern Med. doi:10.7326/M15-2112.
7. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25) (suppl 2):S1-S45.
8. American Diabetes Association. 8: Cardiovascular disease and risk management. Diabetes Care. 2016;39(suppl 1):S60-S71.
9. De Berardis G, Lucisano G, D'Ettorre A, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA. 2012; 307(21):2286-2294.
10. Hernández-Diáz S, Garciá Rodríguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med. 2006;4:22.